Trial intelligence / Profile preview

Suction Curettage vs Botox for Axillary Hyperhidrosis

NCT00669474Phase 4Terminated

Sponsor
Ghent University Hospital
Start
Jun 2009
Primary completion
Aug 2011
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of botulinum toxin type A in primary axillary hyperhidrosis (PAH), sponsored by Ghent University Hospital. Started Jun 2009; status: terminated.

02

Drugs

botulinum toxin type A
03

Conditions

primary axillary hyperhidrosis (PAH)

Beyond the preview

Go deeper on NCT00669474.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00669474.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call